Comments
NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2019 ,inter alia, to consider and approve With reference to the above subject and under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirement) Regulation, 2015, the Exchange is hereby informed that a meeting of Board of Directors of the Company will be held on Saturday, the 09th February, 2019, inter alia, to consider and approve Unaudited Financial Results of the Company for the Quarter ended 31st December, 2018. Further, the trading window shall remain closed from 2nd February, 2019 to 11th February, 2019
Source : BSE - www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.